Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
27 participants
OBSERVATIONAL
2015-04-30
2015-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Accuracy of Detection of Methemoglobin With Pulse Oximetry
NCT03869840
Dysfunctional Hemoglobin Pulse Oximetry
NCT03030833
Accuracy of Pulse CO-Oximetry Technology in Characterizing Noninvasive SpHb
NCT01997502
SpO2 Accuracy Validation of Pulse Oximetry Systems During Motion and Non-Motion Conditions
NCT02475668
Pulse Oximeter Hypoxia
NCT04562584
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pulse Co-Ox
Comparison of pulse co-oximeter to blood gas analyzer.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The subject is of any racial or ethnic group.
* The subject is between 18 years and 45 years of age.
* The subject does not have significant medical problems.
* The subject is willing to provide written informed consent and is willing and able to comply with study procedures.
Exclusion Criteria
* Has had any relevant injury at the sensor location site
* Has deformities or abnormalities that may prevent proper application of the device under test.
* Has a known respiratory condition.
* Is currently a smoker.
* Has a known heart or cardiovascular condition.
* Is currently pregnant.
* Is female and actively trying to get pregnant.
* Has a clotting disorder.
* Has Raynaud's Disease.
* Is known to have a hemoglobinopathy such as (anemia, bilirubinemia, sickle-cell anemia, inherited or congenital methemoglobinemia).
* The subject has a COHb greater than 3% or MetHb greater than 2%.
* Has taken blood thinners or medication with aspirin within the last 24 hours.
* Has unacceptable collateral circulation from the ulnar artery.
* Has donated more than 300 mL of blood within one month prior to start of study.
* Is unwilling or unable to provide written informed consent to participate in the study.
* Is unwilling or unable to comply with the study procedures for the primary objectives.
* Has another health condition which in the opinion of the principal investigator makes him/her unsuitable for testing.
18 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nonin Medical, Inc
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Phillip E Bickler, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University of California, San Francisco
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of California San Francisco
San Francisco, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
QATP2687
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.